Delek Group’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
$14.3M Buy
408,303
+95,192
+30% +$3.34M 0.55% 63
2019
Q1
$11.5M Buy
313,111
+149,676
+92% +$5.5M 0.48% 73
2018
Q4
$7.23M Buy
163,435
+63,815
+64% +$2.82M 0.33% 87
2018
Q3
$4.68M Buy
+99,620
New +$4.68M 0.2% 112